SEC Form 4 reporting owner

Shenouda Maged

Shenouda Maged has filed 4 Form 4 transactions reported between December 12, 2025 and September 10, 2026, as Chief Financial Officer of RELMADA THERAPEUTICS, INC..

Name as filed: Shenouda Maged

Open-market buys, 24 mo
$892K
3 lines
Open-market sales, 24 mo
None
reported
Companies
1
with Form 4 filings
Latest transaction
Sep 10, 2026
transaction date

Roles and reported holdings

  • RLMDRELMADA THERAPEUTICS, INC.
    Dec 12, 2025 – Sep 10, 2026

    Chief Financial Officer

    Held directly1,000,000 sh as of Sep 10, 2026 · Form 4

    24 months: $892K bought

Transaction history

All 4 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Sep 10, 2026RLMDChief Financial OfficerOpen-market purchaseCode P · direct79,800$339K@ $4.25Form 4
Sep 9, 2026RLMDChief Financial OfficerOpen-market purchaseCode P · direct120,200$505K@ $4.20Form 4
Dec 15, 2025RLMDChief Financial OfficerOpen-market purchaseCode P · direct11,665$48K@ $4.12Form 4
Dec 12, 2025RLMDChief Financial OfficerGrant or awardCode A · direct828,000—Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.